Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Breastcancer.org Podcast

ART Doesn’t Increase Hormone Receptor-Positive Breast Cancer Recurrence Risk

07 Dec 2023

Description

At the 2023 San Antonio Breast Cancer Symposium, Dr. Hatem Azim presented a new analysis of information from the POSITIVE trial, which found that younger women diagnosed with early-stage, hormone receptor-positive breast cancer could safely pause hormonal therapy to try to become pregnant. His new analysis looked at whether the women could use fertility preservation and assisted reproductive technologies (ART) without increasing the risk of the cancer coming back (recurrence). Listen to the podcast to hear Dr. Azim discuss: the types of fertility preservation and ART used which techniques were the most successful the results of his analysis

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.